Why the study?
ARVC is a rare genetic disorder that increases the risk of ventricular arrhythmias and sudden cardiac death, particularly in young people and athletes.
Answers are grounded in this paper and cite their sources.
This case report illustrates the presentation of ARVC as out-of-hospital cardiac arrest in a young patient and the appropriate use of ICD for secondary prevention.
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is a rare genetic disorder characterized by the replacement of the right ventricular myocardium with fibrous and fatty tissue, increasing the risk of ventricular arrhythmias and sudden cardiac death (SCD), particularly in young people and athletes. We would like to present a case report of a 23-year-old female who presented with out-of-hospital cardiac arrest due to ventricular fibrillation. Initial resuscitative approaches included cardiopulmonary resuscitation, defibrillation shock and administration of amiodarone, followed by intensive care management. The patient was diagnosed with ARVC and underwent implantable cardioverter-defibrillator (ICD) placement for secondary prevention of SCD. With a review of medical literature, we would like to discuss our approach, diagnosis, and treatment for ARVC.
No takes yet. Share an insight, caveat, or question.
A 2024 study studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: